Diabetes and Your Eyes: Why Early Detection Changes Everything

Diabetes is widely understood as a systemic disease — one that affects the heart, kidneys, nerves, and circulation. What is less commonly appreciated is that the eyes are among the earliest and most consistently affected organs. Diabetic eye disease develops silently, often without any change in vision, which means the window for meaningful intervention can close before a patient ever notices a problem.¹

Your Annual Exam Is About More Than Your Prescription

Glasses and contacts are important — but they are only part of what we do at your annual wellness exam. Getting your prescription right improves your day-to-day quality of life. Monitoring the health of your eyes protects your long-term vision. Both matter equally, and both happen at the same visit.

For patients with diabetes — or a family history of it — the health screening portion of that exam carries particular weight. Our primary goals are to determine your most accurate prescription and to screen for early signs of diabetic ocular involvement before symptoms develop. If anything is detected, we schedule a dedicated follow-up medical exam for a more targeted approach to diagnosis, monitoring, and management. That distinction in appointment type allows us to give your eye health the focused attention it deserves.

What Diabetes Does to the Eye

Chronic elevated blood sugar damages the small blood vessels throughout the body — and the retina, located at the back of the eye, is densely supplied by those vessels. Over time, this leads to diabetic retinopathy: leakage, swelling, abnormal vessel growth, and in advanced cases, vision-threatening hemorrhage or retinal detachment.²

Retinopathy is the most common complication, but diabetes can affect multiple structures of the eye — including the lens, the optic nerve, and the cornea. A brief mention of these is worth raising so patients know the scope of what we are evaluating, though the specifics of each are best discussed during an individualized medical visit.

Why You May Have No Symptoms — and Why That Matters

One of the most clinically important facts about diabetic eye disease is that significant retinal damage can be present with no change in vision whatsoever. Patients frequently assume that stable vision means healthy eyes. It does not. By the time vision is affected, the disease is often at an advanced stage where treatment options are more limited and outcomes less predictable.¹,³

This is precisely why consistent monitoring — rather than waiting for symptoms — is the standard of care.

How We Evaluate Diabetic Eye Health

Dilated Fundus Examination (DFE) remains the foundational component of diabetic eye care. Dilation allows direct visualization of the retina, optic nerve, and vasculature. We look for microaneurysms, hemorrhages, exudates, and neovascularization — the hallmark findings of progressive retinopathy. This is also where patient education happens in real time: we use retinal images to walk patients through exactly what we are looking at and why, comparing their images to reference examples of both healthy and affected retinas to make the findings tangible.

Optomap with OCT Mac Screening provides a wide-field retinal image capturing approximately 82% of the retina alongside a macular OCT screener — both in a single session, available at your first visit for less than the cost of an oil change or vehicle inspection. For diabetic patients, wide-field imaging is particularly valuable because peripheral retinal changes — which are common in diabetes — can be missed with standard examination alone.⁴

ERG (Electroretinography) measures the functional response of the retinal cells to light. In diabetes, ERG can detect subtle reductions in photoreceptor and inner retinal cell function before structural changes are visible on imaging — providing an early functional signal that adds meaningful context to what we see structurally.⁵

Zeiss OCT (Macular Protocol) is introduced when screening findings indicate the need for closer evaluation.

High-resolution cross-sectional imaging of the macula allows us to detect and quantify diabetic macular edema — swelling within the retinal layers — and monitor its progression or response to treatment over time.

Co-Management and Systemic Communication

Diabetic eye care does not happen in isolation. We communicate our findings directly to your primary care physician or endocrinologist to ensure that your ocular health status is part of your broader diabetes management picture. While glycemic control — including close attention to blood sugar levels and A1C — is primarily managed by your PCP or endocrinologist, we reinforce its importance at every visit. The relationship between systemic disease control and ocular outcomes is well-established: better-controlled diabetes correlates directly with slower progression of retinal disease.⁶

Who Should Be Screened

Current clinical guidelines recommend annual dilated eye examinations for all patients with Type 1 or Type 2 diabetes.³ In practice, this means:

- Patients newly diagnosed with diabetes should schedule a baseline ocular evaluation promptly

- Long-term diabetics who have not had a recent dilated exam are overdue, regardless of how their vision feels

- Individuals with a first-degree family member with diabetes carry elevated risk and benefit from early, consistent screening

The Bottom Line

Diabetic eye disease is largely preventable from a vision-loss standpoint — but only when it is caught early and monitored consistently. The technology we use, combined with direct communication with your broader care team, gives us the best possible chance of protecting your sight over the long term. Contact us to schedule your evaluation.

For educational purposes only. Not a substitute for individualized medical care.

Diabetes & Your Eyes

1. Fong DS, et al. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–2553. https://doi.org/10.2337/diacare.27.10.2540

2. Cheung N, et al. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. https://doi.org/10.1016/S0140-6736(09)62124-3

3. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024;47(Suppl 1). https://doi.org/10.2337/dc24-S012

4. Silva PS, et al. Peripheral lesions identified on ultrawide field imaging. Ophthalmology. 2013;120(12):2587–2595.

https://doi.org/10.1016/j.ophtha.2013.05.028

5. Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 1999;44(1):53–60.

https://doi.org/10.1016/S0039-6257(99)00063-6

6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development andprogression of long-term complications. N Engl J Med. 1993;329(14):977–986. https://doi.org/10.1056/NEJM199309303291401